Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Appoints Another Orphan Products Development Office Head Amid Growth Expectations

Oct 15 2018

• By Derrick Gingery

FDABldg1ExteriorWithCircle_1200x675

Related Content

Center Of Excellence Not Best Model For US FDA Rare Disease Program, Woodcock Says

Sep 13 2018

US FDA May Wait Until Late 2019 Before A Cures Hiring Enhancement Is Available

Sep 27 2018

Rare Disease Integration Into FDA Reviews Will Grow Under PDUFA VI

Jul 18 2016

Orphan Designation Requests To Get Slower Reviews

May 11 2016

US FDA's Acting Orphan Products Development Director Has Gene Therapy Background

May 06 2018

US FDA's Streamlined Hiring Pilot Restarts After Delay

Aug 15 2018

FDA's Orphan Designation Backlog Plan Focuses On Efficiency, Not Staff

Jun 29 2017

Additional Topics

United States FDA Rare Diseases Leadership Regulation BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window